AC Immune (ACIU) Current Leases (2019 - 2026)

AC Immune (ACIU) has reported Current Leases for 8 consecutive years, with $1.1 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Leases rose 91594.54% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 91594.54% YoY), while the FY2025 annual figure was $1.0 billion, up 87640.8% from the prior year.
• Current Leases retreated to $1.1 billion in Q1 2026 per ACIU's latest filing, from $1.1 billion in the prior quarter.
• Across five years, Current Leases topped out at $1.1 billion in Q4 2025 and bottomed at $568836.0 in Q4 2022.
• Historically, Current Leases has averaged $241.6 million across 5 years, with a median of $1.1 million in 2025.
• Annual changes were most pronounced in 2022 — Current Leases slumped 99.91% — and 2023, when it surged 133081.13%.
• AC Immune's Current Leases stood at $568836.0 in 2022, then surged by 133081.13% to $757.6 million in 2023, then slumped by 99.85% to $1.2 million in 2024, then soared by 90917.36% to $1.1 billion in 2025, then fell by 1.17% to $1.1 billion in 2026.
• Business Quant data shows ACIU's Current Leases at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.3 million in Q3 2025.